Alpha Omega Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,832
| Closed | -$1.09M | – | 206 |
|
|
2024
Q4 | $1.09M | Sell |
11,832
-37,004
| -76% | -$3.33M | 0.21% | 108 |
|
|
2024
Q3 | $4.09M | Sell |
48,836
-443
| -0.9% | -$33.8K | 0.75% | 43 |
|
|
2024
Q2 | $3.38M | Buy |
49,279
+1,629
| +3% | +$109K | 0.65% | 54 |
|
|
2024
Q1 | $3.49M | Sell |
47,650
-626
| -1% | -$48.1K | 0.65% | 52 |
|
|
2023
Q4 | $3.91M | Sell |
48,276
-150
| -0.3% | -$11.7K | 0.65% | 41 |
|
|
2023
Q3 | $3.63M | Sell |
48,426
-302
| -0.6% | -$23.2K | 0.63% | 41 |
|
|
2023
Q2 | $3.76M | Sell |
48,728
-2,395
| -5% | -$191K | 0.63% | 45 |
|
|
2023
Q1 | $4.24M | Sell |
51,123
-3,343
| -6% | -$277K | 0.73% | 35 |
|
|
2022
Q4 | $4.68M | Sell |
54,466
-10,874
| -17% | -$861K | 0.83% | 32 |
|
|
2022
Q3 | $4.03M | Sell |
65,340
-962
| -1% | -$60.7K | 0.77% | 36 |
|
|
2022
Q2 | $4.1M | Buy |
66,302
+3,088
| +5% | +$191K | 0.73% | 39 |
|
|
2022
Q1 | $3.76M | Buy |
63,214
+11,120
| +21% | +$711K | 0.59% | 51 |
|
|
2021
Q4 | $3.75M | Buy |
52,094
+751
| +1% | +$51.7K | 0.58% | 52 |
|
|
2021
Q3 | $3.59M | Buy |
51,343
+1,627
| +3% | +$114K | 0.59% | 48 |
|
|
2021
Q2 | $3.42M | Buy |
49,716
+3,381
| +7% | +$226K | 0.56% | 51 |
|
|
2021
Q1 | $3M | Buy |
46,335
+2,416
| +6% | +$156K | 0.52% | 57 |
|
|
2020
Q4 | $2.56M | Buy |
43,919
+2,604
| +6% | +$157K | 0.43% | 63 |
|
|
2020
Q3 | $2.61M | Buy |
41,315
+70
| +0.2% | +$4.85K | 0.37% | 59 |
|
|
2020
Q2 | $3.17M | Sell |
41,245
-11,500
| -22% | -$881K | 0.48% | 44 |
|
|
2020
Q1 | $3.94M | Sell |
52,745
-1,361
| -3% | -$94K | 0.73% | 18 |
|
|
2019
Q4 | $3.52M | Buy |
54,106
+1,257
| +2% | +$81.9K | 0.56% | 41 |
|
|
2019
Q3 | $3.46M | Buy |
52,849
+3,673
| +7% | +$240K | 0.56% | 40 |
|
|
2019
Q2 | $3.32M | Buy |
49,176
+488
| +1% | +$32.1K | 1.41% | 30 |
|
|
2019
Q1 | $3.17M | Buy |
48,688
+20,576
| +73% | +$1.37M | 1.42% | 27 |
|
|
2018
Q4 | $1.76M | Sell |
28,112
-20,493
| -42% | -$1.43M | 0.88% | 36 |
|
|
2018
Q3 | $3.75M | Buy |
48,605
+645
| +1% | +$48.7K | 1.68% | 24 |
|
|
2018
Q2 | $3.4M | Buy |
47,960
+767
| +2% | +$54.2K | 1.67% | 22 |
|
|
2018
Q1 | $3.56M | Buy |
47,193
+1,929
| +4% | +$153K | 1.78% | 17 |
|
|
2017
Q4 | $3.24M | Buy |
45,264
+2,897
| +7% | +$220K | 1.59% | 26 |
|
|
2017
Q3 | $3.43M | Buy |
42,367
+561
| +1% | +$42.9K | 1.71% | 17 |
|
|
2017
Q2 | $2.96M | Buy |
41,806
+2,770
| +7% | +$184K | 1.52% | 26 |
|
|
2017
Q1 | $2.65M | Buy |
39,036
+7,269
| +23% | +$511K | 1.41% | 27 |
|
|
2016
Q4 | $2.27M | Buy |
31,767
+5,899
| +23% | +$438K | 1.2% | 34 |
|
|
2016
Q3 | $2.05M | Buy |
25,868
+24,168
| +1,422% | +$1.96M | 1.63% | 33 |
|
|
2016
Q2 | $142K | Hold |
1,700
| – | – | 0.12% | 75 |
|
|
2016
Q1 | $156K | Buy |
1,700
+800
| +89% | +$72.1K | 0.13% | 67 |
|
|
2015
Q4 | $91K | Buy |
+900
| New | +$93.6K | 0.08% | 84 |
|
Other funds holding GILD
Alpha Omega Wealth Management's GILD Position: Q1 2025 in Review
Alpha Omega Wealth Management sold out of Gilead Sciences (GILD) in Q1 2025, closing a stake of 11,832 shares — an estimated $1.09M sold.
Alpha Omega Wealth Management first reported a position in GILD in Q4 2015 and held it in 37 quarters. The position peaked at $4.68M in Q4 2022. 2,014 funds tracked by Wall St. Rank hold GILD as of Q1 2025.
- Alpha Omega Wealth Management reported no remaining Gilead Sciences position as of Q1 2025 after selling out during the quarter.
- Alpha Omega Wealth Management sold 11,832 Gilead Sciences shares in Q1 2025, an estimated $1.09M.
- Alpha Omega Wealth Management first reported a position in Gilead Sciences in Q4 2015 and held it in 37 quarters.
- Alpha Omega Wealth Management's Gilead Sciences position peaked at $4.68M in Q4 2022.
- 2,014 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.
Based on Alpha Omega Wealth Management's 13F filing for Q1 2025, filed 15 Apr 2025.